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Abstract
Background: To investigate the effect of Eurycoma longifolia Jack root extract on serum lipids in rats. Methods:
Twenty-six mature male albino Wistar rats were used in this study. A group of 18 rats were fed a high fat and high
cholesterol diet for 4 weeks, after which their lipid profile was compared to the control group, who were kept on a
normal diet. The rats were then further divided into three groups, the Cf group that continued to feed on a high fat and
cholesterol diet only, and group A and group B who continued on a high fat diet with the addition of 5 mg/kg and 10
mg/kg of Eurycoma longifolia Jack root extract respectively for 4 weeks. After the 4 week period, the rat’s lipid profiles
were analysed again. Results: Group A and B showed significant total cholesterol reduction when compared to the Cf
group, 140 ± 7.23, 139.63 ± 7.95, 192.14 ± 8.96 mg/dL respectively (p < 0.001). The total cholesterol/HDL ratio in
group A was 5 however there was a sharp increase in group B to a high-risk level of 9.2 indicating a significant drop in
HDL levels. The LDL level increased significantly in both group A and B compared to the Cf group. Conclusions:
Eurycoma longifolia Jack root extract is effective in lowering total cholesterol, however the dose needs to be adjusted to
prevent an excessive decrease in HDL levels.
Keywords: wistar rats, cholesterol, Eurycoma longifolia Jack, HDL, LDL

main use of this plant is as a sexual enhancer with
studies proving that it can raise the serum testosterone
levels leading to improved strength and power during
sexual activities and an increase in male virility.9

Introduction
Over the past three decades there has been an increasing
trend to use natural products rather than conventional
treatments as remedies for many diseases.1 A study
conducted in the USA showed that a high percentage of
well-educated people prefer to use alternative medicines.2

Recent studies have also shown that the E.L root has
antibacterial and antifungal properties against human
pathogenic bacteria and fungi.10,11 Additionally, antioxidant
and anti-inflammatory properties were also detected in
the root extract.12

A very common tropical herbal plant in Southeast Asian
countries is Eurycoma longifolia Jack (E.L), which is
also known as Tongkat Ali. This tree is found in the
forests of Burma, China, Thailand, Malaysia, Sumatra,
Borneo, and the Philippines.3 The plant’s roots, stems,
and bark are used as folk medicines for the treatment of
many conditions including fevers, sexual dysfunction,
dysentery, and fatigue. Traditionally the water decoction
of E. longifolia root is consumed orally and research has
shown a wide range of biological activities including
antimalarial, cytotoxic, antiulcer, and antipyretic properties.
These properties may be attributed to the various
quassinoids, squalene derivatives, biphenylneolignans,
tirucallane-type triterpenes, canthine-6-one, and l~carboline alkaloids found in the plant. However, the

Lipids serve several important physiologic functions
within the human body, such as stabilising the cell
membrane and facilitating membrane transport. They
are also important for the biosynthesis of hormones and
the production of bile acids for the absorption of fat in
mammals. Lipids are insoluble in water and must be
packaged into lipoproteins to circulate within the plasma.
The core of the lipoprotein, containing cholesterol ester
and triglycerides (TG), is nonpolar and hydrophobic,
and the outer layer of the lipoprotein particle (containing
free cholesterol, phospholipid, and specific apolipoproteins)
is polarised, permitting the lipoprotein particles to be
25
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transported in the circulation. Each lipoprotein class
(chylomicrons, very low density lipoprotein (VLDL),
Intermediate density lipoprotein (IDL), low density
lipoprotein (LDL), and high density lipoprotein (HDL)
varies in size, density, and lipid composition within the
core of the particle.13
LDL particles carry the majority of the cholesterol in the
blood, supplying cholesterol to the cells. LDL receptors
in peripheral cells or the liver bind with LDLs and clear
it from the blood and the peripheral cells utilise LDL
cholesterol. LDL is an atherogenic lipoprotein particle,
and it is established that higher levels of LDLs are
associated with increased cardiovascular disease risk.14
HDL particles are synthesised and catabolised in the
liver and intestines. Nascent HDL obtains free cholesterol
from peripheral tissues. It is well established that
increased HDL levels are associated with a decreased
risk of coronary heart disease, whereas reduced HDL
levels increase risk. The cardioprotective role of HDLs
is to facilitate the transfer of cholesterol from atherogenic
lipoproteins and peripheral tissues to the liver.15
Hyperlipidaemia involves abnormally elevated levels of
any or all lipids and lipoproteins in the blood.16 Lipid and
lipoprotein abnormalities are common in the general
population and are regarded as a modifiable risk factor
for cardiovascular disease due to their influence on
atherosclerosis.17
Previous studies addressed the effect of testosterone
supplementation on the serum lipid levels of men and
found that the administration of testosterone improved
lipid metabolism by decreasing total cholesterol and
low-density lipoprotein cholesterol.18,19 Researchers
have also found that testosterone administration slows
the process of atherosclerosis and leads to attenuation of
fatty streaks.20
Because the consumption of Eurycoma longifolia Jack
root leads to a rise in serum testosterone levels, we
hypothesised that the root extract would indirectly lead
to a decrease in serum lipid levels.

Methods
The water soluble, freeze-dried extract was purchased
from the Ljack Sdn Bhd Company in Malaysia; the
product was supported by a certificate indicating it was
pure and of a high concentration.
Twenty six mature male albino Wistar rats were used in
this study. The sample size was calculated according to
the resource equation method.21 They were housed in
standard cages and fed on standard pellets for 7 days
before commencing the experiment. Serum cholesterol,
HDL, LDL, and testosterone were analysed using
Makara J. Health Res.

commercial kits manufactured by Abnova, with kit
numbers KA0829, KA1671, and KA0309 respectively.
They were purchased from Axon scientific Sdn Bhd
Malaysia.
Eight rats were randomly chosen to represent the control
group C; they did not receive any dietary changes or
E.L root extract throughout the experiment. At the start
of the experiment fasting serum cholesterol, LDLs, and
HDLs were recorded for the control group. The rest of
the 18 rats were maintained exclusively on a high fat
and high cholesterol diet for 4 weeks. At the end of this
period we analysed the fasting cholesterol, HDLs, and
LDLs for the high fat fed rats.
The 18 high fat fed rats were randomly split into three
groups; the control group that continued to feed on a
high fat diet only (Cf), and group A and B both of which
continued to be fed on a high fat diet with the addition
of E.L root extract. Group A received 5 mg/kg, and
group B received 10 mg/kg of E.L extract twice daily that
was dissolved in 10 mL of distilled water and manually
fed to the rats using a mouth gavage. The treatment
continued for 4 weeks at the end of which, the fasting
serum lipid and testosterone analysis were repeated.
Statistical analysis. Statistical analysis of the data was
carried out using Statistical Package for Social Sciences
(SPSS) version 20.0. One-way analysis of variance and
the Tukey post hoc test for average comparison were
completed. Mean values ± standard deviation were
calculated. Values of p < 0.05 were considered statiscally
significant.
Ethical approval. This research was approved by the
Kulliyyah of Dentistry Research Committee and the
Research Management Centre, of the International Islamic
University of Malaysia, Kuantan Campus, 2100 Kuantan,
Pahang, Malaysia.

Results
The results of this study showed that there was a
statistically significant increase in fasting levels of
Cholesterol, HDLs, and LDLs in the rats fed on high
cholesterol diets when compared to the control group (p
< 0.001). This implies that the high cholesterol diet caused
an elevation of blood lipids. The cholesterol/HDL ratio
was maintained at the same level (Table1).
After administration of the E.L extract the level of blood
lipids found in group A showed a statistically significant
reduction in total cholesterol levels when compared to the
Cf group, 140 ± 7.23, 192.14 ± 8.96 mg/dL respectively.
The total cholesterol of group A dropped down to nearly
the same level as the control group, 136.6 ± 3.77 mg/dL.
The levels of LDLs significantly increased to 74.81 ±
2.21 mg/dL (p < 0.001). However, the HDL levels dropped
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insignificantly to 27.66 ± 1.93 mg/dL (p = 0.209). The
total cholesterol/HDL ratio of group A was equal to 5
(Table 2).
The total cholesterol levels were significantly reduced
in group B when compared with the Cf group, with their
levels being 139.63 ± 7.95 and 192.14 ± 7.76 mg/dL,
respectively (p < 0.001). However, the reduction of total
cholesterol in group B was not statistically significant
from group A (p = 0.729) (Table 3 and Table 4).

Table 3. Shows the mean Fasting Serum Lipid Levels in
the Control Group on a Fat Diet (Cf) and Group B

Cholesterol
HDL
LDL
Testosterone (ng/mL)
Chol/HDL

Cf
Mean ± SD
192.14 ± 7.76
29.24 ± 1.88
48.86 ± 2.06
0.79 ± 0.07
6.50

Group B
Mean ± SD
139.63 ± 7.95*
15.02 ± 0.83*
104.89 ± 2.55*
1.75 ± 0.10*
9.20

*statistically significant p < 0.001

The changes to HDLs and LDLs in group B are more
pronounced as both the decrease in HDLs and the
increase in LDLs are statistically significant when
compared with the Cf group (p < 0.001). Due to the
significant decrease in HDLs, the total cholesterol/HDL
ratio increased greatly to 9.2 in group B (Table 3).
When comparing the results of group A and B, we can
see that the decrease in cholesterol seen in group B is
not significant when compared to group A (p = 0.729).
However, the decrease in HDLs and the increase in
LDLs in group B are statistically different than group A
(p < 0.001) (Table 4).
Testosterone levels were slightly increased in group A
when compared to the Cf group, however the increase
was not significant. In group B, there was a sharp rise in
testosterone levels to 1.75 ± 0.10, which was significantly
higher than the Cf group (p < 0.001). In comparing the
testosterone levels between group A and B, there was a
statistically significant increase in testosterone in group
B (p < 0.001) (Table 2, 3, and 4).
Table 1. Shows the Values of Serum Lipids in the Control
Group before and after a High Cholesterol Diet

Cholesterol
HDL
LDL
Cholesterol/HDL

Control (C)
Mean mg/dL ± SD
136.60 ± 3.77
22.45 ± 1.13
33.36 ± 1.26
6.08

After high fat diet
Mean mg/dL ± SD
192.14 ± 5.79*
29.24 ± 1.11*
48.86 ± 1.34*
6.57

Table 4. Comparison between Group A and B

Cholesterol
HDL
LDL
Testosterone (ng/mL)
Cholesterol/HDL

A
Mean ± SD
140 ± 7.23
27.66 ± 1.93
74.81 ± 2.21
0.89 ± 0.16
5.00

B
Mean ± SD
139.63 ± 7.95
15.03 ± 0.83*
104.89 ± 2.55*
1.75 ± 0.10*
9.20

*statistically significant p < 0.001

Discussion
Modern lifestyle and the increased consumption of a
high fat diet and processed foods has led to an increase
in the serum lipids across different age groups in the
population. This has increased the need for medical
intervention using drugs or invasive techniques to
prevent or treat coronary heart disease, a common
consequence of high blood lipids.22
Raised total cholesterol is a significant risk factor for
coronary heart disease, and the risk is significantly higher
in men than women.23 The currently available lipid
lowering agents are not free from side effects, some of
which are quite serious.24
The current trend in research is to look for natural
resources with medical applications that are safe for
human use as well as being environmentally friendly.

*statistically significant p < 0.001

Table 2. Shows the Mean Fasting Serum Lipid Levels in
the Control Group on a High Fat Diet (Cf ) and
Group A

Cholesterol mg/dL
HDL mg/dL
LDL mg/dL
Testosterone (ng/mL)
Chol/HDL

Cf
Mean ± SD
192.14 ± 8.96
29.24 ± 1.22
48.86 ± 1.79
0.79 ± 0.07
6.50

*statistically significant p < 0.001
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Group A
Mean ± SD
140 ± 7.23*
27.66 ± 1.93
74.81 ± 2.21*
0.89 ± 0.16
5.00

Many recent studies have documented the inverse
relationship between testosterone and cardiovascular
related mortality, stating that low serum testosterone is
associated with increased risk of cardiovascular disease
and mortality, and that increasing endogenous testosterone
can lead to higher survival rates.25-28
Eurycoma longifolia Jack root extract is a well-known
natural product that has been documented as safe for
human use and can be used to increase testosterone
levels in males.29
In this study, we fed sample rats a high cholesterol diet,
which lead to an actual rise in cholesterol levels when
April 2017 | Vol. 21 | No. 1
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compared to the rats fed a normal level. We then used two
different concentrations of E.L root extract administered
twice daily.
In a previously conducted study using the same doses of
E.L root extract, the 10 mg/kg dose resulted in very
sharp rise in testosterone levels when compared to the 5
mg/kg dose.29
In both treatment groups there was a significant lowering
of cholesterol levels in comparison with the Cf group.
However, when comparing the cholesterol levels of group
A and group B, there was no statistically significant
difference (p = 0.729), indicating that an increased E.L
dose does not improve lipid lowering effects (Table 4).
The effect of E.L extract on HDLs and LDLs appears to
be reciprocal as E.L caused a decrease in HDLs and an
increase in LDLs, an effect that is considered unfavourable.
However, studies have shown that the most important
predictor of cardiovascular risk is the total cholesterol/HDL
ratio and not high levels of LDLs alone. It has been
reported that subjects with low LDL cholesterol levels
and high total cholesterol/HDL ratios (>5) had a 2.5
times higher incidence of CHD than those with similar
LDL cholesterol levels and low total cholesterol/HDL
cholesterol ratios.30
Looking at the effect of E.L extract on the cholesterol/
HDL ratio, we found that in group A the ratio was equal
to 5, which means that it is still within the safe range,
however for group B the ratio had increased well beyond
safe levels. The rise in the ratio and the consequent sharp
drop in HDL levels seen in group B can be explained by
the effect of sharply increasing testosterone levels in
this group. Previous studies have shown the effect of
testosterone on lowering HDL cholesterol, a phenomenon
observed in athletes using androgenic-anabolic steroids.31
This effect has also been achieved consistently with the
administration of supraphysiologic doses of oral androgens
in young men, however it is far less consistent when
testosterone therapy is used at physiologic doses to
restore eugonadal serum levels, particularly in older
men. 32,33
As such, we can expect that treatment with 5 mg/kg of
E.L extract should maintain testosterone levels close to
the normal physiological range to help reduce total
cholesterol levels, whilst also maintaining a safe
cholesterol/HDL ratio. While the higher dose of 10
mg/kg led to a significantly higher level of testosterone
leading to a sharp rise in the cholesterol/HDL ratio and
no increased benefit of cholesterol lowering ability.

Conclusions
E.L root extract is beneficial in lowering total cholesterol
level, however the dose should be regulated to prevent
Makara J. Health Res.

unnecessary lowering of HDL levels. This extract may
be useful to lower total cholesterol as well as helping to
return testosterone to normal physiological levels in
elderly males with hypercholesterolaemia.
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